Pathway for patients with suspected colorectal cancer

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

Karen Pocock Skin Cancer Clinical Nurse Specialist
A Case Study GP Masterclass Catherine Dale, RN, BSc Cancer Care
Merseyside and Cheshire Cancer Network HEPATO BILIARY MULTIDISCIPLINIARY TEAM MEETING Referral to Specialist HPB (Liver) MDT, University Hospital, Aintree,
Prostate Cancer Support Federation Charity Nº: We have no national screening programme for the most common cancer in men and the only test we.
Guidance on Cancer Services Improving Outcomes for People with Skin Tumours including Melanoma NICE Stateholder Consultation version July 2005.
Bowel Cancer Alex Hill. Why screen for bowel cancer?  Bowel cancer causes deaths per yr  It may be detected at asymptomatic stage by simple, safe.
Acute Oncology Service (AOS) Monday – Friday 8am – 4pm Bleep: 946 T: x5726 F: Dr Nicola Beech Dr Jillian Noble Dr Susannah.
Breast cancer patient pathway
Facts about the Trust £110 million pound turnover 1,619 staff plus staff employed by contractors 33,365 inpatient and day cases were treated 10,670 elective.
Imaging Metastatic Rectal Cancer Jack Temple, MS3 June 2013 Christian Malalis, MD.
Organized Diagnostic Assessment Demonstration Projects Organized Diagnostic Assessment Demonstration Projects Grand River Regional Diagnostic Assessment.
PET in Colorectal Cancer. Indications for FDG PET Rising marker, (-) CT/MRI Nonspecific findings on CT/MRI, recurrence or post treatment changes? Known.
SETTING UP THE SERVICE BY LYNN TOBIN. HOW DID WE GET HERE? ABUNDENCE OF EVIDENCE PROVIDING JUSTIFICATION FOR BOWEL CANCER SCREENING.
Anal Cancer - Case 1  62 years old woman with 6 months history of anal pain  Clinically T 3 squamous cell carcinoma growing anteriorly  Which staging.
The Good, The Bad and The Patient Choice! Colorectal Patient Pathways Across the Network Presented by: Teresa Coombes Cancer, Oncology, Haematology and.
Gynaecology MDT Coordinator
LUCADA Jacqueline Brown Cancer Services Manager North Tees & Hartlepool Trust.
Synchronous Metastasis on Staging/Surveillance CT chest abdomen & Pelvis + CEA + MRI Liver /PET-CT Synchronous Metastasis on Staging/Surveillance CT chest.
Network Audit Patients with Confirmed Small Cell Lung Cancer Who Did Not Receive Chemotherapy Dr D N Leitch On Behalf of Lung Cancer NSSG NECN.
Flexible Sigmoidoscopy And Whole Colon Imaging In The Diagnosis Of Cancer In Patients With Colorectal Symptoms Peter O’Leary Journal Club 13/10/08.
Summary The National Clinical Pathway represents a pathway that is achievable now, requiring no extra resources but reliant on appropriate logistics. The.
Two-week wait referrals for malignant melanoma: A clinical audit carried out across four UK Cancer Networks South West Cancer Intelligence Service
Straight to Test Colonoscopy Pilot Sas Banerjee, Matt Hanson, Aman Bhargava and Joseph Huang Consultant General & Colorectal Surgeons Noel Thin & Paul.
MULTI-DISCIPLINARY CANCER MANAGEMENT John B. Hamner, MD, FACS Assistant Professor Surgical Oncology Tulane University.
National Optimal Clinical Pathway for suspected and confirmed lung cancer: Referral to treatment Note: this was previously circulated for discussion as.
National Clinical Pathway for suspected and confirmed lung cancer:
WiFi name: WifiLoveMCR Password: internet Join the conversation on Twitter using #DrivingChange
SMDT SMDT SMDT Synchronous Metastasis on Staging/Surveillance
2 November John Childs and Deborah Woodley
An Electronic 2 Week Wait Referral System for Colorectal Cancer
Fig. 1 Frequency distribution of initial palliative treatment modalities used. EBRT, external beam radiotherapy. Initial palliative treatment modality.
BREAST CANCER ONCOLOGY NAVIGATION SERVICE
Coordination (benign lesions)
NICE Guidance – Service delivery for patients with Sarcomas
Segmented analysis of prostate cancer pathway from referral to treatment: This work was carried out in partnership between the Transforming.
Recognition and Referral of Suspected cancer NICE NG12 – 2Week Wait
Mr Michael Thomas, Colorectal Cancer SSG, 27th June 2018
Pathway for patients with suspected Breast Cancer
4 NW (in-pt) REFERRAL & TREATMENT PATHWAY Referral Enter here Sources
Six stage journey When diagnosed with a brain tumour.
18 Weeks Referral To Treatment Waiting Times Standard
Katie’s story: Advanced colorectal cancer
Segmented analysis of the lung cancer median pathway from referral to treatment: This work was carried out in partnership between the Transforming.
Cancer Waiting Times Standards
Pathway for patients with suspected Skin Cancer
Pathway for patients with suspected Upper GI (OG) Cancer
Neuro Oncology Therapy Update
Hannah Marder Cancer Manager UH Bristol
The BAHNO Head & Neck Cancer Surveillance Audit 2018
Current and Future Treatment Options: Neurosurgery
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance
Early Diagnosis Diagnostics Cancer Waits Survivorship South West Cancer Network 14 November 2014.
Worcestershire Colorectal Cancer 2ww Pathway
The BAHNO Head & Neck Cancer Surveillance Audit 2018
2018 National Mesothelioma Audit
24 februari 2019 Process Mining in de Gezondheidszorg BPM round table session Dr.ir. Ronny Mans.
Two Week Wait Referral Forms
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance
Pathway for patients with suspected HPB Cancer Inter Provider Transfer
4 NW (in-pt) REFERRAL & TREATMENT PATHWAY Referral Enter here Sources
Early and locally advanced breast cancer
Pathway for patients with suspected Breast Cancer
Breast Multidisciplinary Team Meetings
28 Day Faster Diagnosis Standard
Airedale NHS Foundation Trust
Living With & Beyond Cancer (Personalised Care): SWAG Colorectal CAG Update 5th June 2019 Catherine Neck, Macmillan Cancer Rehabilitation/ LWBC Lead On.
Standardised follow-up
NHS Long Term Plan: Rapid Diagnostic Centres (RDC) The SWAG Approach
NCRI and NHS England LWBC Event Somerset Cancer Register
Presentation transcript:

Pathway for patients with suspected colorectal cancer Maximum Wait (days) Pathway for patients with suspected colorectal cancer Referral received in secondary care 14 days First Seen Straight to test Colorectal Diagnostic Service Colonoscopy +/- biopsy Flexible sigmoidoscopy 14 Provide information and appropriate level of psychological support throughout the patient journey Colorectal cancer clinically or histologically probable? No Provide patient with information and remove from Cancer Pathway 16-18 years old – refer to Paediatric Oncology (GNCC) for treatment and TYA MDT for discussion 19-24 years old – continue on tumour site specific pathway & refer to TYA MDT for discussion. See TYA pathway Yes Holistic assessment and rehabilitation consideration CT chest abdomen/pelvis MRI pelvis EUA USS Endo anal U/S Staging Investigations Allocate Colorectal CNS Inform patient’s GP of Serious Diagnosis 17 days MDT review of results, plan treatment and consider suitability for clinical trials See Colorectal Rehabilitation Care Pathway liaise and involve healthcare professionals as required Inter Provider Transfer Network Best Practice 31 Outpatient appointment to discuss results and agree treatment options 15 days Decision to Treat 46 16 days First Treatment Chemotherapy Radiotherapy Surgical Resection Supportive Palliative Care 62 Restaging CT/MRI MDT review of treatment plan and consideration for clinical trials Earliest Clinically Appropriate Date (ECAD) For commencement of subsequent treatment Appropriate after care Colorectal Cancer Pathway [final]